GoodRx Holdings (GDRX) Return on Sales (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Sales retreated to 0.0% in Q1 2026, from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q2 2023 to a low of 0.0% in Q3 2022.
• A 5-year average of 0.0% and a median of 0.0% in 2026 frame the typical range for Return on Sales.
• Peak annual rise in Return on Sales reached 0 bps in 2022, while the deepest fall reached 0 bps in 2022.
• Tracing GDRX's Return on Sales over 5 years: stood at 0.0% in 2022, then slumped by 1128 bps to 0.0% in 2023, then surged by 126 bps to 0.0% in 2024, then decreased by 18 bps to 0.0% in 2025, then tumbled by 78 bps to 0.0% in 2026.
• Business Quant data shows GDRX's Return on Sales at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.